Search - BrightTALK

Easing the Outsider Access Audit

Fernando Sosa at HaonTech.com and Camille Shipes Childs at U.S. Dermatology Partners

Healthcare organizations are regularly opening up their networks to an increasing number of third parties. Sadly, the access granted to third parties ...

4 weeks ago 58 mins

Drug and Device Development Secrets in the World of Medical Aesthetics

Jasmina Jankicevic, MD, MSc, CCRP, Dermatologist, Nach Davé, RPh, Marlis Sarkany, MD, MSc

New treatment options for aesthetic indications are in record-high demand, fueled by an aging population, and a growing focus on aesthetic issues rela...

9 months ago 61 mins

Essential Strategies in Dermatology Clinical Trials

Jasmina Jankicevic, MD, Vice President, Medical Affairs & Asya Tsaneva-Maksimova, Director Study Start-up

Essential Strategies in Dermatology Clinical Trials: The Convergence of Patients, Regulations, and Study Design Competition for patients among sponso...

1 year ago 62 mins

Asia-Pacific – Taking Device Clinical Development to the US & Europe

Nach Dave, RPh. MSc, Vice President, Development Strategy and Marlis Sarkany, MD Senior Medical Director

Medical devices play an increasingly critical role in the health and quality of life for millions of people worldwide. While clinical trials for medic...

1 year ago 61 mins

미용 의학세계의의약품 및 의료기기개발의 비밀

Jasmina Jankicevic, 피부과 전문의, 의학박사(MD), 이학석사, 국제 임상연구 전문가(CCRP)*, Nach Davé, 약사(RPh.)*, 이학석사, Marlis Sarkany, 의학박사(MD), 이학석사

미용 의학의 트렌드: 미용 의학 트렌드, 미용 의학 및 의료 기기 개발, 특히 지난 20 년 동안 미용 시장이 어떻게 진화하고 성장해 왔는지에 초점을 맞출 것입니다. 생리 기능 저하, 환경 스트레스에 대한 적응력 감소, 라이프 스타일이 피부 건강에 미치는 영향에 대한 ...

10 months ago 51 mins

미용 의학세계의의약품 및 의료기기개발의 비밀

Jasmina Jankicevic, 피부과 전문의, 의학박사(MD), 이학석사, 국제 임상연구 전문가(CCRP)*, Nach Davé, 약사(RPh.)*, 이학석사, Marlis Sarkany, 의학박사(MD), 이학석사

미용 의학의 트렌드: 미용 의학 트렌드, 미용 의학 및 의료 기기 개발, 특히 지난 20 년 동안 미용 시장이 어떻게 진화하고 성장해 왔는지에 초점을 맞출 것입니다. 생리 기능 저하, 환경 스트레스에 대한 적응력 감소, 라이프 스타일이 피부 건강에 미치는 영향에 대한 ...

10 months ago 51 mins

Setting a Real-World Strategy in an Evolving Clinical Research Environment

Stacy Weil - Senior Vice President of Clinical Informatics & Nach Dave, RPh. MSc, Vice President, Development Strategy

Since early this year, many standard clinical trial processes have been significantly disrupted. Patients have been prevented from attending regular p...

1 year ago 59 mins

임상규정 업무(RA) U.S. FDA's Pharmaceutical Regulatory Affairs

발표자인 Kirsti Miller는 Premier Research 의 RA 전문 자회사인 RPI 그룹에서 Head of RA 로 근무중이신 임상규정업무의 전문가 입니다.

국내 스폰서 분들의 FDA IND 제출 시 주요 고려 사항 *웨비나: 인터넷상의 세미나 국내 스폰서분들이 미국 FDA 임상계획승인(IND)진행 시 FDA기준에 부합하도록 지원하는 자사의 임상규정 서비스에 대해서 발표 예정입니다. - 미국 FDA 임상시험계획승인 제출...

11 months ago 20 mins

Strengthening Neuroscience Clinical Research Through Innovation

Juliet Moritz and Barry Dussault

There’s a lot of discussions these days about innovative ideas to make clinical research more patient-focused. The concept goes hand-in-hand with the ...

2 years ago 63 mins

FDA 505(b)(2) 경로 : 더 빠른 임상단계의 진입

Ken Phelps President & Founder

이 웨비나에서 Ken Phelps, 사장/설립자는 505(B)(2)경로에 대한 몇 가지 일반적인 오해를 다룰 것입니다. 대부분의 사람들은 스폰서가 모든 연구를 수행하며, 승인을 위한 매우 잘 확립된 경로가 있는 전통적인 약물 개발인 505(B)(1)경로에 대해 많은 경...

3 months ago 33 mins

Improving Regulatory and Operational Performance in Orphan Drug Development

Nach Davé and Kimberly Glen

Today more than ever, regulatory bodies are providing a progressive platform for rare disease drug development. Extensions to existing regulations and...

2 years ago 57 mins

Operationalizing Fibromyalgia Trials

Scott Millard

Scott Millard of Premier Research reviews how to best operationalize fibromyalgia clinical trials in a 2017 APS Town Hall Talk in Pittsburgh, PA.

2 years ago 27 mins

초기 종양학 연구에서 적응적 임상시험 디자인 (Adaptive Trial Design)의 역할: 유연성과 민첩성의 최적화

Abie Ekangaki, 박사(PhD) 부회장 생물통계학 컨설팅 담당 Peter J. Larson, 의사(MD) 전무이사 의료 담당

우리는 종양학 정밀 의학 연구에서 적응적 임상시험 디자인의 역할에 대한 몇 가지 높은 수준의 통찰력을 제시할 것입니다. 이러한 적응적 임상시험 디자인이 유연성과 민첩성을 최적화하는데 어떻게 도움이 되는지 알아보고자 합니다. 이것은 몇 가지 관점을 제시하고 향후 디자인 ...

6 months ago 44 mins

Modernizing Your RBQM Program with Automation and Integration

Kristin Mauri, Remarque Systems and Ron Burns, BA Insight

A well-functioning risk-based quality monitoring (RBQM) program is a must-have for today’s clinical organizations. Historically, some RBQM systems ha...

7 months ago 30 mins

Asia-Pacific – Taking Device Clinical Development to the US & Europe

Nach Dave, RPh. MSc, Vice President, Development Strategy and Marlis Sarkany, MD Senior Medical Director

Medical devices play an increasingly critical role in the health and quality of life for millions of people worldwide. While clinical trials for medic...

1 year ago 61 mins

Considerations to Improve Patient Outcomes in Early Drug Development

Abie Ekangaki, Ph.D., VP, Premier Research; Rupa Doshi, ‎Ph.D., VP, Premier Research; Naomi Kautz, Sr Director, RPI

Every drug development program must begin with an understanding of how the relevant key stakeholders factor into the development process. It’s not jus...

February 10, 2022 3:00pm

Initiation & Execution of Early Oncology Clinical Trials in the Time of COVID-19

Luke Gill, B.Sc. (Hon), M.Sc., MBA and Peter Larson, M.D.

Initiation and Execution of Early Oncology Clinical Trials in the Time of COVID-19 Early-phase oncology, emerging from the crisis, and research and in...

1 year ago 46 mins

Immuno-Gene Therapeutics in Hematological Cancers: How Science Drives Study Stra

Colin Hayward and Luke Gill

This webcast will review the current state of technology in gene therapeutics and examine trends in immuno-oncology and gene therapy for hematological...

2 years ago 62 mins

파킨슨병 유전자 치료법 추구: 전략 및 운영 요구사항

Andreas Schreiner, MD 부회장, 신경과학 및 진통 분야 의료 담당

웨비나는 파킨슨병 유전자 치료의 역사와 현황에 대해 논의하고, 몇 가지 과제와 연구를 공유하고, 미래 전망을 공유하는 것입니다. 그런 다음 이러한 연구와 관련된 임상 규제, 운영 고려 사항 및 과제에 대해 논의합니다. 어젠다: 파킨스병(Parkinson’s Diseas...

2 months ago 44 mins

Discussion of Dermatology Competitive Intelligence Tool

Abby Lockwood

Join us for a free, live webinar to explore how our customized market intelligence reports keep you abreast of developments in dermatology and provide...

8 years ago 29 mins

Dermatological Coding Complexities and Opportunities for Fraud, Waste and Abuse

Lindsay Surynt, Investigator, and Katherine Bass, Investigator, General Dynamics Health Solutions

Dermatology is a complex clinical specialty comprising hundreds of procedure codes for surgical services related to lesion removals, biopsies and exci...

5 years ago 53 mins

Measuring How Well Subjects Know and Do in Neuropsychiatric Trials

Thomas Laage

Measuring How Well Subjects Know and Do in Neuropsychiatric Trials

2 years ago 54 mins

The Potential For Disease-Modifying Therapies In Parkinson’s Disease

Andreas Schreiner and Barry Dussault

Parkinson’s disease is a progressive neurodegenerative disease that strikes its victims in the prime of their lives. Most available treatments have re...

2 years ago 62 mins

Operational & Regulatory Factors in Cross-Border Enrollment in Rare Disorders

Hanna Wide Director, Program Delivery Rare Diseases & Pediatrics at Premier Research

Researchers are more focused than ever on finding treatments and cures for rare diseases, encouraged by a regulatory environment that is increasingly ...

1 year ago 19 mins

Empowering Oncology Patients to Maximize Study Outcomes

Ashley Herrick, Ph.D., Exec. Dir., Oncology Program Strategy & Nicole Carswell, Exec. Dir., Patient Engagement & Recruitment

Patient recruitment comprises one of the most significant initial challenges in any oncology study but engaging and retaining these patients throughou...

February 24, 2022 3:00pm

Search results

Brighttalk site footer content